Contents

Current Pharmaceutical Design, Volume 17 - Number 19

Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]

, 17(19): 1872 - 1873

Bernard Degryse


DOI: 10.2174/138161211796718161




The Urokinase Receptor Interactome

, 17(19): 1874 - 1889

Gabriele Eden, Marco Archinti, Federico Furlan, Ronan Murphy and Bernard Degryse


DOI: 10.2174/138161211796718215




Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients

, 17(19): 1890 - 1910

Martin C. Boonstra, Hein W. Verspaget, Sjam Ganesh, Frank J.G.M. Kubben, Alexander L. Vahrmeijer, Cornelis J.H. van de Velde, Peter J.K. Kuppen, Paul H.A. Quax and Cornelis F.M. Sier


DOI: 10.2174/138161211796718233




The Urokinase Receptor in Hematopoietic Stem Cells Mobilization

, 17(19): 1911 - 1913

Francesco Blasi


DOI: 10.2174/138161211796718206




The Role of the Urokinase Receptor in Epilepsy, in Disorders of Language, Cognition, Communication and Behavior, and in the Central Nervous System

, 17(19): 1914 - 1923

Nadine Bruneau and Pierre Szepetowski


DOI: 10.2174/138161211796718198




The Urokinase Receptor System, A Key Regulator at the Intersection between Inflammation, Immunity, and Coagulation

, 17(19): 1924 - 1943

Mario Del Rosso, Francesca Margheri, Simona Serrati, Anastasia Chilla, Anna Laurenzana and Gabriella Fibbi


DOI: 10.2174/138161211796718189




The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling

, 17(19): 1944 - 1961

Maria Vincenza Carriero and Maria Patrizia Stoppelli


DOI: 10.2174/138161211796718143




Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)

, 17(19): 1962 - 1969

Steven L. Gonias, Alban Gaultier and Minji Jo


DOI: 10.2174/138161211796718224




Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic

, 17(19): 1970 - 1978

Andrew P. Mazar, Richard W. Ahn and Thomas V. O'Halloran


DOI: 10.2174/138161211796718152




Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy

, 17(19): 1979 - 1983

Maddalena de Virgilio and Franco Silvestris


DOI: 10.2174/138161211796718170




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science